Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Alpha 1 Antitrypsin Deficiency Treatment Market 2018, Forecast to 2023
Severe deficiency of alpha-1 antitrypsin (AAT) can cause early-onset emphysema and several liver diseases, including cirrhosis, neonatal hepatitis and hepatocellular carcinoma.
Scope of the Report:
This report focuses on the Alpha 1 Antitrypsin Deficiency Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The discovery of the structure and function of the AAT protein and the subsequent isolation and purification thereof have made possible alternative therapies aimed at preventing the progression of related pulmonary diseases (so-called "additional therapies"). The isolation of this gene and the advancement of gene therapy have further increased the possibility of specific treatment. Most specific treatments for AAT deficiency aim to increase plasma AAT levels (and thus elevated AAT concentrations in the interstitial lung) above the protection threshold. Other experimental therapeutic approaches attempt to interfere with the production of abnormal AAT proteins or to inhibit the polymerization of abnormal AAT proteins and to promote the secretion of AAT from hepatocytes. For patients with end-stage lung disease or liver disease, organ transplantation is another treatment option.
Currently, the most direct and effective way to increase AAT levels in plasma and interstitial lung is by intravenous infusion of pooled alpha-1 antitrypsin (pAAT).
The worldwide market for Alpha 1 Antitrypsin Deficiency Treatment is expected to grow at a CAGR of roughly 9.0% over the next five years, will reach 1980 million US$ in 2023, from 1190 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Alpha 1 Antitrypsin Deficiency Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Alpha 1 Antitrypsin Deficiency Treatment, with sales, revenue, and price of Alpha 1 Antitrypsin Deficiency Treatment, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Alpha 1 Antitrypsin Deficiency Treatment, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Alpha 1 Antitrypsin Deficiency Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Alpha 1 Antitrypsin Deficiency Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Scope of the Report:
This report focuses on the Alpha 1 Antitrypsin Deficiency Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The discovery of the structure and function of the AAT protein and the subsequent isolation and purification thereof have made possible alternative therapies aimed at preventing the progression of related pulmonary diseases (so-called "additional therapies"). The isolation of this gene and the advancement of gene therapy have further increased the possibility of specific treatment. Most specific treatments for AAT deficiency aim to increase plasma AAT levels (and thus elevated AAT concentrations in the interstitial lung) above the protection threshold. Other experimental therapeutic approaches attempt to interfere with the production of abnormal AAT proteins or to inhibit the polymerization of abnormal AAT proteins and to promote the secretion of AAT from hepatocytes. For patients with end-stage lung disease or liver disease, organ transplantation is another treatment option.
Currently, the most direct and effective way to increase AAT levels in plasma and interstitial lung is by intravenous infusion of pooled alpha-1 antitrypsin (pAAT).
The worldwide market for Alpha 1 Antitrypsin Deficiency Treatment is expected to grow at a CAGR of roughly 9.0% over the next five years, will reach 1980 million US$ in 2023, from 1190 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Pfizer
- Baxter
- AstraZeneca
- Grifols
- Teva Pharmaceutical Industries
- Boehringer Ingelheim
- Kamada Ltd
- GlaxoSmithKline
- CSL Behring
- Shire
- LFB Biomedicaments
- Abeona Therapeutics
- Biogen
- Applied Genetic Technologies
- Baxalta
- Arrowhead Research Corporation
- ProBioGen
- Chiesi Pharmaceuticals
- Curaxys
- ProMetic Life Sciences
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Augmentation Therapy
- Bronchodilators
- Corticosteroids
- Oxygen Therapy
- Hospitals
- Specialty Clinics
- Pharmacies
Chapter 1, to describe Alpha 1 Antitrypsin Deficiency Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Alpha 1 Antitrypsin Deficiency Treatment, with sales, revenue, and price of Alpha 1 Antitrypsin Deficiency Treatment, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Alpha 1 Antitrypsin Deficiency Treatment, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Alpha 1 Antitrypsin Deficiency Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Alpha 1 Antitrypsin Deficiency Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW
1.1 Alpha 1 Antitrypsin Deficiency Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Augmentation Therapy
1.2.2 Bronchodilators
1.2.3 Corticosteroids
1.2.4 Oxygen Therapy
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Specialty Clinics
1.3.3 Pharmacies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Business Overview
2.1.1.1 Pfizer Description
2.1.1.2 Pfizer Headquarter, Main Business and Finance Overview
2.1.2 Pfizer Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.1.2.1 Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
2.1.2.2 Alpha 1 Antitrypsin Deficiency Treatment Product Information
2.1.3 Pfizer Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Pfizer Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Pfizer Alpha 1 Antitrypsin Deficiency Treatment Market Share in 2017
2.2 Baxter
2.2.1 Business Overview
2.2.1.1 Baxter Description
2.2.1.2 Baxter Headquarter, Main Business and Finance Overview
2.2.2 Baxter Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.2.2.1 Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
2.2.2.2 Alpha 1 Antitrypsin Deficiency Treatment Product Information
2.2.3 Baxter Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Baxter Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Baxter Alpha 1 Antitrypsin Deficiency Treatment Market Share in 2017
2.3 AstraZeneca
2.3.1 Business Overview
2.3.1.1 AstraZeneca Description
2.3.1.2 AstraZeneca Headquarter, Main Business and Finance Overview
2.3.2 AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.3.2.1 Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
2.3.2.2 Alpha 1 Antitrypsin Deficiency Treatment Product Information
2.3.3 AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Market Share in 2017
2.4 Grifols
2.4.1 Business Overview
2.4.1.1 Grifols Description
2.4.1.2 Grifols Headquarter, Main Business and Finance Overview
2.4.2 Grifols Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.4.2.1 Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
2.4.2.2 Alpha 1 Antitrypsin Deficiency Treatment Product Information
2.4.3 Grifols Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Grifols Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Grifols Alpha 1 Antitrypsin Deficiency Treatment Market Share in 2017
2.5 Teva Pharmaceutical Industries
2.5.1 Business Overview
2.5.1.1 Teva Pharmaceutical Industries Description
2.5.1.2 Teva Pharmaceutical Industries Headquarter, Main Business and Finance Overview
2.5.2 Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.5.2.1 Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
2.5.2.2 Alpha 1 Antitrypsin Deficiency Treatment Product Information
2.5.3 Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Market Share in 2017
2.6 Boehringer Ingelheim
2.6.1 Business Overview
2.6.1.1 Boehringer Ingelheim Description
2.6.1.2 Boehringer Ingelheim Headquarter, Main Business and Finance Overview
2.6.2 Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.6.2.1 Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
2.6.2.2 Alpha 1 Antitrypsin Deficiency Treatment Product Information
2.6.3 Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Market Share in 2017
2.7 Kamada Ltd
2.7.1 Business Overview
2.7.1.1 Kamada Ltd Description
2.7.1.2 Kamada Ltd Headquarter, Main Business and Finance Overview
2.7.2 Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.7.2.1 Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
2.7.2.2 Alpha 1 Antitrypsin Deficiency Treatment Product Information
2.7.3 Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Market Share in 2017
2.8 GlaxoSmithKline
2.8.1 Business Overview
2.8.1.1 GlaxoSmithKline Description
2.8.1.2 GlaxoSmithKline Headquarter, Main Business and Finance Overview
2.8.2 GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.8.2.1 Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
2.8.2.2 Alpha 1 Antitrypsin Deficiency Treatment Product Information
2.8.3 GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Market Share in 2017
2.9 CSL Behring
2.9.1 Business Overview
2.9.1.1 CSL Behring Description
2.9.1.2 CSL Behring Headquarter, Main Business and Finance Overview
2.9.2 CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.9.2.1 Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
2.9.2.2 Alpha 1 Antitrypsin Deficiency Treatment Product Information
2.9.3 CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Market Share in 2017
2.10 Shire
2.10.1 Business Overview
2.10.1.1 Shire Description
2.10.1.2 Shire Headquarter, Main Business and Finance Overview
2.10.2 Shire Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.10.2.1 Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
2.10.2.2 Alpha 1 Antitrypsin Deficiency Treatment Product Information
2.10.3 Shire Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Shire Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Shire Alpha 1 Antitrypsin Deficiency Treatment Market Share in 2017
2.11 LFB Biomedicaments
2.11.1 Business Overview
2.11.2 LFB Biomedicaments Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.11.3 LFB Biomedicaments Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Abeona Therapeutics
2.12.1 Business Overview
2.12.2 Abeona Therapeutics Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.12.3 Abeona Therapeutics Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Biogen
2.13.1 Business Overview
2.13.2 Biogen Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.13.3 Biogen Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Applied Genetic Technologies
2.14.1 Business Overview
2.14.2 Applied Genetic Technologies Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.14.3 Applied Genetic Technologies Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Baxalta
2.15.1 Business Overview
2.15.2 Baxalta Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.15.3 Baxalta Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Arrowhead Research Corporation
2.16.1 Business Overview
2.16.2 Arrowhead Research Corporation Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.16.3 Arrowhead Research Corporation Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 ProBioGen
2.17.1 Business Overview
2.17.2 ProBioGen Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.17.3 ProBioGen Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Chiesi Pharmaceuticals
2.18.1 Business Overview
2.18.2 Chiesi Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.18.3 Chiesi Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Curaxys
2.19.1 Business Overview
2.19.2 Curaxys Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.19.3 Curaxys Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 ProMetic Life Sciences
2.20.1 Business Overview
2.20.2 ProMetic Life Sciences Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.20.3 ProMetic Life Sciences Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL ALPHA 1 ANTITRYPSIN DEFICIENCY TREATMENT MARKET COMPETITION, BY MANUFACTURER
3.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Alpha 1 Antitrypsin Deficiency Treatment Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Alpha 1 Antitrypsin Deficiency Treatment Manufacturer Market Share in 2017
3.4.2 Top 5 Alpha 1 Antitrypsin Deficiency Treatment Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL ALPHA 1 ANTITRYPSIN DEFICIENCY TREATMENT MARKET ANALYSIS BY REGIONS
4.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales by Regions (2013-2018)
4.1.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue by Regions (2013-2018)
4.2 North America Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA ALPHA 1 ANTITRYPSIN DEFICIENCY TREATMENT BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Countries
5.1.1 North America Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
5.1.2 North America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
5.1.3 United States Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
5.1.4 Canada Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
5.1.5 Mexico Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
5.2 North America Alpha 1 Antitrypsin Deficiency Treatment Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturers (2016-2017)
5.2.2 North America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturers (2016-2017)
5.3 North America Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Alpha 1 Antitrypsin Deficiency Treatment Sales and Sales Share by Type (2013-2018)
5.3.2 North America Alpha 1 Antitrypsin Deficiency Treatment Revenue and Revenue Share by Type (2013-2018)
5.4 North America Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Alpha 1 Antitrypsin Deficiency Treatment Sales and Sales Share by Application (2013-2018)
5.4.2 North America Alpha 1 Antitrypsin Deficiency Treatment Revenue and Revenue Share by Application (2013-2018)
6 EUROPE ALPHA 1 ANTITRYPSIN DEFICIENCY TREATMENT BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Countries
6.1.1 Europe Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
6.1.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
6.1.3 Germany Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
6.1.4 UK Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
6.1.5 France Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
6.1.6 Russia Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
6.1.7 Italy Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
6.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturers (2016-2017)
6.2.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturers (2016-2017)
6.3 Europe Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Alpha 1 Antitrypsin Deficiency Treatment Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Alpha 1 Antitrypsin Deficiency Treatment Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC ALPHA 1 ANTITRYPSIN DEFICIENCY TREATMENT BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
7.1.3 China Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
7.1.4 Japan Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
7.1.5 Korea Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
7.1.6 India Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA ALPHA 1 ANTITRYPSIN DEFICIENCY TREATMENT BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Countries
8.1.1 South America Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
8.1.2 South America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
8.1.3 Brazil Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
8.1.4 Argentina Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
8.1.5 Colombia Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
8.2 South America Alpha 1 Antitrypsin Deficiency Treatment Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturers (2016-2017)
8.2.2 South America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturers (2016-2017)
8.3 South America Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Alpha 1 Antitrypsin Deficiency Treatment Sales and Sales Share by Type (2013-2018)
8.3.2 South America Alpha 1 Antitrypsin Deficiency Treatment Revenue and Revenue Share by Type (2013-2018)
8.4 South America Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Alpha 1 Antitrypsin Deficiency Treatment Sales and Sales Share by Application (2013-2018)
8.4.2 South America Alpha 1 Antitrypsin Deficiency Treatment Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA ALPHA 1 ANTITRYPSIN DEFICIENCY TREATMENT BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
9.1.4 UAE Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
9.1.5 Egypt Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
9.1.7 South Africa Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL ALPHA 1 ANTITRYPSIN DEFICIENCY TREATMENT MARKET SEGMENT BY TYPE
10.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales and Market Share by Type (2013-2018)
10.1.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue and Market Share by Type (2013-2018)
10.2 Augmentation Therapy Sales Growth and Price
10.2.1 Global Augmentation Therapy Sales Growth (2013-2018)
10.2.2 Global Augmentation Therapy Price (2013-2018)
10.3 Bronchodilators Sales Growth and Price
10.3.1 Global Bronchodilators Sales Growth (2013-2018)
10.3.2 Global Bronchodilators Price (2013-2018)
10.4 Corticosteroids Sales Growth and Price
10.4.1 Global Corticosteroids Sales Growth (2013-2018)
10.4.2 Global Corticosteroids Price (2013-2018)
10.5 Oxygen Therapy Sales Growth and Price
10.5.1 Global Oxygen Therapy Sales Growth (2013-2018)
10.5.2 Global Oxygen Therapy Price (2013-2018)
11 GLOBAL ALPHA 1 ANTITRYPSIN DEFICIENCY TREATMENT MARKET SEGMENT BY APPLICATION
11.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Specialty Clinics Sales Growth (2013-2018)
11.4 Pharmacies Sales Growth (2013-2018)
12 ALPHA 1 ANTITRYPSIN DEFICIENCY TREATMENT MARKET FORECAST (2018-2023)
12.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Growth Rate (2018-2023)
12.2 Alpha 1 Antitrypsin Deficiency Treatment Market Forecast by Regions (2018-2023)
12.2.1 North America Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
12.2.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
12.2.3 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
12.2.4 South America Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
12.2.5 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
12.3 Alpha 1 Antitrypsin Deficiency Treatment Market Forecast by Type (2018-2023)
12.3.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Type (2018-2023)
12.3.2 Global Alpha 1 Antitrypsin Deficiency Treatment Market Share Forecast by Type (2018-2023)
12.4 Alpha 1 Antitrypsin Deficiency Treatment Market Forecast by Application (2018-2023)
12.4.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Application (2018-2023)
12.4.2 Global Alpha 1 Antitrypsin Deficiency Treatment Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
1.1 Alpha 1 Antitrypsin Deficiency Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Augmentation Therapy
1.2.2 Bronchodilators
1.2.3 Corticosteroids
1.2.4 Oxygen Therapy
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Specialty Clinics
1.3.3 Pharmacies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Business Overview
2.1.1.1 Pfizer Description
2.1.1.2 Pfizer Headquarter, Main Business and Finance Overview
2.1.2 Pfizer Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.1.2.1 Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
2.1.2.2 Alpha 1 Antitrypsin Deficiency Treatment Product Information
2.1.3 Pfizer Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Pfizer Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Pfizer Alpha 1 Antitrypsin Deficiency Treatment Market Share in 2017
2.2 Baxter
2.2.1 Business Overview
2.2.1.1 Baxter Description
2.2.1.2 Baxter Headquarter, Main Business and Finance Overview
2.2.2 Baxter Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.2.2.1 Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
2.2.2.2 Alpha 1 Antitrypsin Deficiency Treatment Product Information
2.2.3 Baxter Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Baxter Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Baxter Alpha 1 Antitrypsin Deficiency Treatment Market Share in 2017
2.3 AstraZeneca
2.3.1 Business Overview
2.3.1.1 AstraZeneca Description
2.3.1.2 AstraZeneca Headquarter, Main Business and Finance Overview
2.3.2 AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.3.2.1 Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
2.3.2.2 Alpha 1 Antitrypsin Deficiency Treatment Product Information
2.3.3 AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Market Share in 2017
2.4 Grifols
2.4.1 Business Overview
2.4.1.1 Grifols Description
2.4.1.2 Grifols Headquarter, Main Business and Finance Overview
2.4.2 Grifols Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.4.2.1 Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
2.4.2.2 Alpha 1 Antitrypsin Deficiency Treatment Product Information
2.4.3 Grifols Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Grifols Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Grifols Alpha 1 Antitrypsin Deficiency Treatment Market Share in 2017
2.5 Teva Pharmaceutical Industries
2.5.1 Business Overview
2.5.1.1 Teva Pharmaceutical Industries Description
2.5.1.2 Teva Pharmaceutical Industries Headquarter, Main Business and Finance Overview
2.5.2 Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.5.2.1 Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
2.5.2.2 Alpha 1 Antitrypsin Deficiency Treatment Product Information
2.5.3 Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Market Share in 2017
2.6 Boehringer Ingelheim
2.6.1 Business Overview
2.6.1.1 Boehringer Ingelheim Description
2.6.1.2 Boehringer Ingelheim Headquarter, Main Business and Finance Overview
2.6.2 Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.6.2.1 Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
2.6.2.2 Alpha 1 Antitrypsin Deficiency Treatment Product Information
2.6.3 Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Market Share in 2017
2.7 Kamada Ltd
2.7.1 Business Overview
2.7.1.1 Kamada Ltd Description
2.7.1.2 Kamada Ltd Headquarter, Main Business and Finance Overview
2.7.2 Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.7.2.1 Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
2.7.2.2 Alpha 1 Antitrypsin Deficiency Treatment Product Information
2.7.3 Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Market Share in 2017
2.8 GlaxoSmithKline
2.8.1 Business Overview
2.8.1.1 GlaxoSmithKline Description
2.8.1.2 GlaxoSmithKline Headquarter, Main Business and Finance Overview
2.8.2 GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.8.2.1 Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
2.8.2.2 Alpha 1 Antitrypsin Deficiency Treatment Product Information
2.8.3 GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Market Share in 2017
2.9 CSL Behring
2.9.1 Business Overview
2.9.1.1 CSL Behring Description
2.9.1.2 CSL Behring Headquarter, Main Business and Finance Overview
2.9.2 CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.9.2.1 Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
2.9.2.2 Alpha 1 Antitrypsin Deficiency Treatment Product Information
2.9.3 CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Market Share in 2017
2.10 Shire
2.10.1 Business Overview
2.10.1.1 Shire Description
2.10.1.2 Shire Headquarter, Main Business and Finance Overview
2.10.2 Shire Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.10.2.1 Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
2.10.2.2 Alpha 1 Antitrypsin Deficiency Treatment Product Information
2.10.3 Shire Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Shire Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Shire Alpha 1 Antitrypsin Deficiency Treatment Market Share in 2017
2.11 LFB Biomedicaments
2.11.1 Business Overview
2.11.2 LFB Biomedicaments Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.11.3 LFB Biomedicaments Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Abeona Therapeutics
2.12.1 Business Overview
2.12.2 Abeona Therapeutics Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.12.3 Abeona Therapeutics Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Biogen
2.13.1 Business Overview
2.13.2 Biogen Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.13.3 Biogen Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Applied Genetic Technologies
2.14.1 Business Overview
2.14.2 Applied Genetic Technologies Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.14.3 Applied Genetic Technologies Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Baxalta
2.15.1 Business Overview
2.15.2 Baxalta Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.15.3 Baxalta Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Arrowhead Research Corporation
2.16.1 Business Overview
2.16.2 Arrowhead Research Corporation Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.16.3 Arrowhead Research Corporation Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 ProBioGen
2.17.1 Business Overview
2.17.2 ProBioGen Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.17.3 ProBioGen Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Chiesi Pharmaceuticals
2.18.1 Business Overview
2.18.2 Chiesi Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.18.3 Chiesi Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Curaxys
2.19.1 Business Overview
2.19.2 Curaxys Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.19.3 Curaxys Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 ProMetic Life Sciences
2.20.1 Business Overview
2.20.2 ProMetic Life Sciences Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
2.20.3 ProMetic Life Sciences Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL ALPHA 1 ANTITRYPSIN DEFICIENCY TREATMENT MARKET COMPETITION, BY MANUFACTURER
3.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Alpha 1 Antitrypsin Deficiency Treatment Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Alpha 1 Antitrypsin Deficiency Treatment Manufacturer Market Share in 2017
3.4.2 Top 5 Alpha 1 Antitrypsin Deficiency Treatment Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL ALPHA 1 ANTITRYPSIN DEFICIENCY TREATMENT MARKET ANALYSIS BY REGIONS
4.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales by Regions (2013-2018)
4.1.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue by Regions (2013-2018)
4.2 North America Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA ALPHA 1 ANTITRYPSIN DEFICIENCY TREATMENT BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Countries
5.1.1 North America Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
5.1.2 North America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
5.1.3 United States Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
5.1.4 Canada Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
5.1.5 Mexico Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
5.2 North America Alpha 1 Antitrypsin Deficiency Treatment Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturers (2016-2017)
5.2.2 North America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturers (2016-2017)
5.3 North America Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Alpha 1 Antitrypsin Deficiency Treatment Sales and Sales Share by Type (2013-2018)
5.3.2 North America Alpha 1 Antitrypsin Deficiency Treatment Revenue and Revenue Share by Type (2013-2018)
5.4 North America Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Alpha 1 Antitrypsin Deficiency Treatment Sales and Sales Share by Application (2013-2018)
5.4.2 North America Alpha 1 Antitrypsin Deficiency Treatment Revenue and Revenue Share by Application (2013-2018)
6 EUROPE ALPHA 1 ANTITRYPSIN DEFICIENCY TREATMENT BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Countries
6.1.1 Europe Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
6.1.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
6.1.3 Germany Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
6.1.4 UK Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
6.1.5 France Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
6.1.6 Russia Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
6.1.7 Italy Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
6.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturers (2016-2017)
6.2.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturers (2016-2017)
6.3 Europe Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Alpha 1 Antitrypsin Deficiency Treatment Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Alpha 1 Antitrypsin Deficiency Treatment Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC ALPHA 1 ANTITRYPSIN DEFICIENCY TREATMENT BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
7.1.3 China Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
7.1.4 Japan Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
7.1.5 Korea Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
7.1.6 India Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA ALPHA 1 ANTITRYPSIN DEFICIENCY TREATMENT BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Countries
8.1.1 South America Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
8.1.2 South America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
8.1.3 Brazil Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
8.1.4 Argentina Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
8.1.5 Colombia Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
8.2 South America Alpha 1 Antitrypsin Deficiency Treatment Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturers (2016-2017)
8.2.2 South America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturers (2016-2017)
8.3 South America Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Alpha 1 Antitrypsin Deficiency Treatment Sales and Sales Share by Type (2013-2018)
8.3.2 South America Alpha 1 Antitrypsin Deficiency Treatment Revenue and Revenue Share by Type (2013-2018)
8.4 South America Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Alpha 1 Antitrypsin Deficiency Treatment Sales and Sales Share by Application (2013-2018)
8.4.2 South America Alpha 1 Antitrypsin Deficiency Treatment Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA ALPHA 1 ANTITRYPSIN DEFICIENCY TREATMENT BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
9.1.4 UAE Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
9.1.5 Egypt Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
9.1.7 South Africa Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL ALPHA 1 ANTITRYPSIN DEFICIENCY TREATMENT MARKET SEGMENT BY TYPE
10.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales and Market Share by Type (2013-2018)
10.1.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue and Market Share by Type (2013-2018)
10.2 Augmentation Therapy Sales Growth and Price
10.2.1 Global Augmentation Therapy Sales Growth (2013-2018)
10.2.2 Global Augmentation Therapy Price (2013-2018)
10.3 Bronchodilators Sales Growth and Price
10.3.1 Global Bronchodilators Sales Growth (2013-2018)
10.3.2 Global Bronchodilators Price (2013-2018)
10.4 Corticosteroids Sales Growth and Price
10.4.1 Global Corticosteroids Sales Growth (2013-2018)
10.4.2 Global Corticosteroids Price (2013-2018)
10.5 Oxygen Therapy Sales Growth and Price
10.5.1 Global Oxygen Therapy Sales Growth (2013-2018)
10.5.2 Global Oxygen Therapy Price (2013-2018)
11 GLOBAL ALPHA 1 ANTITRYPSIN DEFICIENCY TREATMENT MARKET SEGMENT BY APPLICATION
11.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Specialty Clinics Sales Growth (2013-2018)
11.4 Pharmacies Sales Growth (2013-2018)
12 ALPHA 1 ANTITRYPSIN DEFICIENCY TREATMENT MARKET FORECAST (2018-2023)
12.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Growth Rate (2018-2023)
12.2 Alpha 1 Antitrypsin Deficiency Treatment Market Forecast by Regions (2018-2023)
12.2.1 North America Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
12.2.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
12.2.3 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
12.2.4 South America Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
12.2.5 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
12.3 Alpha 1 Antitrypsin Deficiency Treatment Market Forecast by Type (2018-2023)
12.3.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Type (2018-2023)
12.3.2 Global Alpha 1 Antitrypsin Deficiency Treatment Market Share Forecast by Type (2018-2023)
12.4 Alpha 1 Antitrypsin Deficiency Treatment Market Forecast by Application (2018-2023)
12.4.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Application (2018-2023)
12.4.2 Global Alpha 1 Antitrypsin Deficiency Treatment Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
LIST OF TABLES AND FIGURES
Figure Alpha 1 Antitrypsin Deficiency Treatment Picture
Table Product Specifications of Alpha 1 Antitrypsin Deficiency Treatment
Figure Global Alpha 1 Antitrypsin Deficiency Treatment CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Alpha 1 Antitrypsin Deficiency Treatment by Types in 2017
Figure Augmentation Therapy Picture
Table Major Manufacturers of Augmentation Therapy
Figure Bronchodilators Picture
Table Major Manufacturers of Bronchodilators
Figure Corticosteroids Picture
Table Major Manufacturers of Corticosteroids
Figure Oxygen Therapy Picture
Table Major Manufacturers of Oxygen Therapy
Figure Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Applications in 2017
Figure Hospitals Picture
Figure Specialty Clinics Picture
Figure Pharmacies Picture
Figure United States Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure France Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure UK Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure China Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure India Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Table Pfizer Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
Table Pfizer Alpha 1 Antitrypsin Deficiency Treatment Product
Table Pfizer Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in 2017
Figure Global Pfizer Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share in 2017
Table Baxter Headquarter, Established, Main Business and Finance Overview (2017)
Table Baxter Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
Table Baxter Alpha 1 Antitrypsin Deficiency Treatment Product
Table Baxter Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Baxter Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in 2017
Figure Global Baxter Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share in 2017
Table AstraZeneca Headquarter, Established, Main Business and Finance Overview (2017)
Table AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
Table AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Product
Table AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in 2017
Figure Global AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share in 2017
Table Grifols Headquarter, Established, Main Business and Finance Overview (2017)
Table Grifols Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
Table Grifols Alpha 1 Antitrypsin Deficiency Treatment Product
Table Grifols Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Grifols Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in 2017
Figure Global Grifols Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share in 2017
Table Teva Pharmaceutical Industries Headquarter, Established, Main Business and Finance Overview (2017)
Table Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
Table Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Product
Table Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in 2017
Figure Global Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share in 2017
Table Boehringer Ingelheim Headquarter, Established, Main Business and Finance Overview (2017)
Table Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
Table Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Product
Table Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in 2017
Figure Global Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share in 2017
Table Kamada Ltd Headquarter, Established, Main Business and Finance Overview (2017)
Table Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
Table Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Product
Table Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in 2017
Figure Global Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share in 2017
Table GlaxoSmithKline Headquarter, Established, Main Business and Finance Overview (2017)
Table GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
Table GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Product
Table GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in 2017
Figure Global GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share in 2017
Table CSL Behring Headquarter, Established, Main Business and Finance Overview (2017)
Table CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
Table CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Product
Table CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in 2017
Figure Global CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share in 2017
Table Shire Headquarter, Established, Main Business and Finance Overview (2017)
Table Shire Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
Table Shire Alpha 1 Antitrypsin Deficiency Treatment Product
Table Shire Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Shire Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in 2017
Figure Global Shire Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share in 2017
Table LFB Biomedicaments
Table LFB Biomedicaments Alpha 1 Antitrypsin Deficiency Treatment
Table Abeona Therapeutics
Table Abeona Therapeutics Alpha 1 Antitrypsin Deficiency Treatment
Table Biogen
Table Biogen Alpha 1 Antitrypsin Deficiency Treatment
Table Applied Genetic Technologies
Table Applied Genetic Technologies Alpha 1 Antitrypsin Deficiency Treatment
Table Baxalta
Table Baxalta Alpha 1 Antitrypsin Deficiency Treatment
Table Arrowhead Research Corporation
Table Arrowhead Research Corporation Alpha 1 Antitrypsin Deficiency Treatment
Table ProBioGen
Table ProBioGen Alpha 1 Antitrypsin Deficiency Treatment
Table Chiesi Pharmaceuticals
Table Chiesi Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment
Table Curaxys
Table Curaxys Alpha 1 Antitrypsin Deficiency Treatment
Table ProMetic Life Sciences
Table ProMetic Life Sciences Alpha 1 Antitrypsin Deficiency Treatment
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturer (2016-2017)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2016
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2017
Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturer (2016-2017)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2016
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2017
Table Global Alpha 1 Antitrypsin Deficiency Treatment Price by Manufacturer (2016-2017)
Figure Top 3 Alpha 1 Antitrypsin Deficiency Treatment Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Alpha 1 Antitrypsin Deficiency Treatment Manufacturer (Revenue) Market Share in 2017
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales by Regions (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Regions (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue by Regions (2013-2018)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Regions in 2013
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Regions in 2017
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure South America Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure South America Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries (2013-2018)
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries in 2013
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries in 2017
Table North America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries in 2013
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries in 2017
Figure United States Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Canada Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Mexico Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturer (2016-2017)
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2016
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2017
Table North America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturer (2016-2017)
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2016
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2017
Table North America Alpha 1 Antitrypsin Deficiency Treatment Sales by Type (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Type (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Type (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Type (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Sales by Application (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Application (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Application (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Application (2013-2018)
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries in 2016
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries in 2017
Figure Germany Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure UK Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure France Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Russia Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Italy Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturer (2016-2017)
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2016
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2017
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturer (2016-2017)
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2016
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2017
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Sales by Type (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Type (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue by Type (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Type (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Sales by Application (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Application (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue by Application (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Application (2013-2018)
Figure Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries 2017
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
Figure Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries 2017
Figure China Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Japan Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Korea Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure India Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales by Type (2013-2018)
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Type (2013-2018)
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue by Type (2013-2018)
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Type (2013-2018)
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales by Application (2013-2018)
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Application (2013-2018)
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue by Application (2013-2018)
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Application (2013-2018)
Figure South America Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries (2013-2018)
Figure South America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries in 2017
Table South America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries in 2017
Figure Brazil Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Argentina Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Colombia Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturer (2016-2017)
Figure South America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2016
Figure South America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2017
Table South America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturer (2016-2017)
Figure South America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2016
Figure South America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2017
Table South America Alpha 1 Antitrypsin Deficiency Treatment Sales by Type (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Type (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Type (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Type (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Sales by Application (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Application (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Application (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Application (2013-2018)
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries in 2017
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries in 2013
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure UAE Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Egypt Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Nigeria Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure South Africa Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales by Type (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Type (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue by Type (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Type (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales by Application (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Application (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue by Application (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Application (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales by Type (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Type (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue by Type (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Type (2013-2018)
Figure Global Augmentation Therapy Sales Growth (2013-2018)
Figure Global Augmentation Therapy Price (2013-2018)
Figure Global Bronchodilators Sales Growth (2013-2018)
Figure Global Bronchodilators Price (2013-2018)
Figure Global Corticosteroids Sales Growth (2013-2018)
Figure Global Corticosteroids Price (2013-2018)
Figure Global Oxygen Therapy Sales Growth (2013-2018)
Figure Global Oxygen Therapy Price (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales by Application (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Application (2013-2018)
Figure Global Hospitals Sales Growth (2013-2018)
Figure Global Specialty Clinics Sales Growth (2013-2018)
Figure Global Pharmacies Sales Growth (2013-2018)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Growth Rate (2018-2023)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Regions (2018-2023)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Market Share Forecast by Regions (2018-2023)
Figure North America Sales Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
Figure Europe Sales Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
Figure Asia-Pacific Sales Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
Figure South America Sales Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
Figure Middle East and Africa Sales Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Type (2018-2023)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Market Share Forecast by Type (2018-2023)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Application (2018-2023)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Figure Alpha 1 Antitrypsin Deficiency Treatment Picture
Table Product Specifications of Alpha 1 Antitrypsin Deficiency Treatment
Figure Global Alpha 1 Antitrypsin Deficiency Treatment CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Alpha 1 Antitrypsin Deficiency Treatment by Types in 2017
Figure Augmentation Therapy Picture
Table Major Manufacturers of Augmentation Therapy
Figure Bronchodilators Picture
Table Major Manufacturers of Bronchodilators
Figure Corticosteroids Picture
Table Major Manufacturers of Corticosteroids
Figure Oxygen Therapy Picture
Table Major Manufacturers of Oxygen Therapy
Figure Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Applications in 2017
Figure Hospitals Picture
Figure Specialty Clinics Picture
Figure Pharmacies Picture
Figure United States Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure France Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure UK Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure China Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure India Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Growth Rate (2013-2023)
Table Pfizer Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
Table Pfizer Alpha 1 Antitrypsin Deficiency Treatment Product
Table Pfizer Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in 2017
Figure Global Pfizer Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share in 2017
Table Baxter Headquarter, Established, Main Business and Finance Overview (2017)
Table Baxter Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
Table Baxter Alpha 1 Antitrypsin Deficiency Treatment Product
Table Baxter Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Baxter Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in 2017
Figure Global Baxter Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share in 2017
Table AstraZeneca Headquarter, Established, Main Business and Finance Overview (2017)
Table AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
Table AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Product
Table AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in 2017
Figure Global AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share in 2017
Table Grifols Headquarter, Established, Main Business and Finance Overview (2017)
Table Grifols Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
Table Grifols Alpha 1 Antitrypsin Deficiency Treatment Product
Table Grifols Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Grifols Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in 2017
Figure Global Grifols Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share in 2017
Table Teva Pharmaceutical Industries Headquarter, Established, Main Business and Finance Overview (2017)
Table Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
Table Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Product
Table Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in 2017
Figure Global Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share in 2017
Table Boehringer Ingelheim Headquarter, Established, Main Business and Finance Overview (2017)
Table Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
Table Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Product
Table Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in 2017
Figure Global Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share in 2017
Table Kamada Ltd Headquarter, Established, Main Business and Finance Overview (2017)
Table Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
Table Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Product
Table Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in 2017
Figure Global Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share in 2017
Table GlaxoSmithKline Headquarter, Established, Main Business and Finance Overview (2017)
Table GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
Table GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Product
Table GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in 2017
Figure Global GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share in 2017
Table CSL Behring Headquarter, Established, Main Business and Finance Overview (2017)
Table CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
Table CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Product
Table CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in 2017
Figure Global CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share in 2017
Table Shire Headquarter, Established, Main Business and Finance Overview (2017)
Table Shire Alpha 1 Antitrypsin Deficiency Treatment Production Bases, Sales Regions and Major Competitors
Table Shire Alpha 1 Antitrypsin Deficiency Treatment Product
Table Shire Alpha 1 Antitrypsin Deficiency Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Shire Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in 2017
Figure Global Shire Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share in 2017
Table LFB Biomedicaments
Table LFB Biomedicaments Alpha 1 Antitrypsin Deficiency Treatment
Table Abeona Therapeutics
Table Abeona Therapeutics Alpha 1 Antitrypsin Deficiency Treatment
Table Biogen
Table Biogen Alpha 1 Antitrypsin Deficiency Treatment
Table Applied Genetic Technologies
Table Applied Genetic Technologies Alpha 1 Antitrypsin Deficiency Treatment
Table Baxalta
Table Baxalta Alpha 1 Antitrypsin Deficiency Treatment
Table Arrowhead Research Corporation
Table Arrowhead Research Corporation Alpha 1 Antitrypsin Deficiency Treatment
Table ProBioGen
Table ProBioGen Alpha 1 Antitrypsin Deficiency Treatment
Table Chiesi Pharmaceuticals
Table Chiesi Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment
Table Curaxys
Table Curaxys Alpha 1 Antitrypsin Deficiency Treatment
Table ProMetic Life Sciences
Table ProMetic Life Sciences Alpha 1 Antitrypsin Deficiency Treatment
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturer (2016-2017)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2016
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2017
Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturer (2016-2017)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2016
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2017
Table Global Alpha 1 Antitrypsin Deficiency Treatment Price by Manufacturer (2016-2017)
Figure Top 3 Alpha 1 Antitrypsin Deficiency Treatment Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Alpha 1 Antitrypsin Deficiency Treatment Manufacturer (Revenue) Market Share in 2017
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales by Regions (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Regions (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue by Regions (2013-2018)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Regions in 2013
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Regions in 2017
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure South America Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure South America Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries (2013-2018)
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries in 2013
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries in 2017
Table North America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries in 2013
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries in 2017
Figure United States Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Canada Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Mexico Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturer (2016-2017)
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2016
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2017
Table North America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturer (2016-2017)
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2016
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2017
Table North America Alpha 1 Antitrypsin Deficiency Treatment Sales by Type (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Type (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Type (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Type (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Sales by Application (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Application (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Application (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Application (2013-2018)
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries in 2016
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries in 2017
Figure Germany Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure UK Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure France Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Russia Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Italy Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturer (2016-2017)
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2016
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2017
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturer (2016-2017)
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2016
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2017
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Sales by Type (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Type (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue by Type (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Type (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Sales by Application (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Application (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue by Application (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Application (2013-2018)
Figure Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries 2017
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
Figure Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries 2017
Figure China Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Japan Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Korea Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure India Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales by Type (2013-2018)
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Type (2013-2018)
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue by Type (2013-2018)
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Type (2013-2018)
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales by Application (2013-2018)
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Application (2013-2018)
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue by Application (2013-2018)
Table Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Application (2013-2018)
Figure South America Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries (2013-2018)
Figure South America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries in 2017
Table South America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries in 2017
Figure Brazil Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Argentina Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Colombia Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturer (2016-2017)
Figure South America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2016
Figure South America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2017
Table South America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturer (2016-2017)
Figure South America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2016
Figure South America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2017
Table South America Alpha 1 Antitrypsin Deficiency Treatment Sales by Type (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Type (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Type (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Type (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Sales by Application (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Application (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Application (2013-2018)
Table South America Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Application (2013-2018)
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries in 2017
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries in 2013
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure UAE Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Egypt Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure Nigeria Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Figure South Africa Alpha 1 Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales by Type (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Type (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue by Type (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Type (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales by Application (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Application (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue by Application (2013-2018)
Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Application (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales by Type (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Type (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue by Type (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Type (2013-2018)
Figure Global Augmentation Therapy Sales Growth (2013-2018)
Figure Global Augmentation Therapy Price (2013-2018)
Figure Global Bronchodilators Sales Growth (2013-2018)
Figure Global Bronchodilators Price (2013-2018)
Figure Global Corticosteroids Sales Growth (2013-2018)
Figure Global Corticosteroids Price (2013-2018)
Figure Global Oxygen Therapy Sales Growth (2013-2018)
Figure Global Oxygen Therapy Price (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales by Application (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Application (2013-2018)
Figure Global Hospitals Sales Growth (2013-2018)
Figure Global Specialty Clinics Sales Growth (2013-2018)
Figure Global Pharmacies Sales Growth (2013-2018)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Growth Rate (2018-2023)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Regions (2018-2023)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Market Share Forecast by Regions (2018-2023)
Figure North America Sales Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
Figure Europe Sales Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
Figure Asia-Pacific Sales Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
Figure South America Sales Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
Figure Middle East and Africa Sales Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2023)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Type (2018-2023)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Market Share Forecast by Type (2018-2023)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Application (2018-2023)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
